Skip to content

The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects

The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03065582
Enrollment
32
Registered
2017-02-28
Start date
2018-03-13
Completion date
2019-04-22
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pigmentation

Brief summary

Visible light is known to induce pigmentation in darker skin types. The investigators aim to study the effects of visible light on the skin after topical application of sunscreen plus antioxidant.

Interventions

OTHERTopical Product A

topical application sunscreen containing topical antioxidants and sunscreen filters

OTHERTopical Product B

topical application of product A without topical antioxidants

OTHERTopical Product C

Topical application of antioxidants only

OTHERControl

No product applied

Sponsors

Allergan
CollaboratorINDUSTRY
Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient age 18 and older * Patients Fitzpatrick skin phototype IV-VI * Patient able to understand requirements of the study and risks involved * Patient able to sign a consent form

Exclusion criteria

* A recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post inflammatory hyperpigmentation * A known history of photodermatoses * A known history of melanoma or non-melanoma skin cancers * Those planning on going to the tanning parlors * Using any of the photosensitizing medication within the visible light range or additional medications at the discretion of the investigator (examples include (but not limited to) thiazide diuretics, regular use of NSAIDs, hydroxychloroquine, or voriconazole) * A woman who is lactating, pregnant, or planning to become pregnant * Patient planning on exposing the irradiated or control areas to the sun * known allergy to anesthetics (lidocaine or epinephrine)

Design outcomes

Primary

MeasureTime frameDescription
diffuse reflectance spectroscopyBaseline- immediately after irradiation to assess immediate pigment darkeningDiffuse reflectance spectroscopy is a non-invasive objective measure of pigmentation based on reflectance patterns of the irradiated skin
photographyBaseline-immediately after irradiation to assess immediate pigment darkeningCross polarized photography is used to document pigmentation non-invasively and reduce surface glare of the skin.
investigator's global assessment scoreBaseline- Immediately after irradiation to assess immediate pigment darkeningThe investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
Diffuse reflectance spectroscopy24 hours after irradiation to assess persistent pigment darkeningDiffuse reflectance spectroscopy is a non-invasive objective measure of pigmentation based on reflectance patterns of the irradiated skin
Investigator's global assessment score24 hours after irradiation to assess persistent pigment darkeningThe investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
Photography7 days after irradiation to assess delayed tanningCross polarized photography is used to document pigmentation non-invasively and reduce surface glare of the skin.
Investigator global assessment score7 days after irradiation to assess delayed tanningThe investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
Biological effects24 hours after irradiationbiopsy with melanocyte and melanin stains to assess pigmentation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026